ArticleScientific reports2026
Effects of zinc supplementation forms (ZnO, Zn-Lysine, Nano-ZnO) on growth performance and metabolic health in pre-weaned Holstein calves.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pre-weaning period is critical because early-life nutrition and management influence growth, metabolic function and Rumen development, thereby affecting subsequent productivity in dairy calves. Zinc (Zn) supplementation plays a key role in supporting these processes through its involvement in enzymatic activity, antioxidant defense systems, and metabolic regulation, but conventional sources often have bioavailability limitations due to the formation of insoluble complexes in the gastrointestinal tract. This study addresses this challenge by evaluating three Zn forms (ZnO, Zn-lysine, and nano-ZnO) to identify the most effective source for enhancing growth rates, nutrient utilization, and metabolic health. Twenty-four newborn Holstein calves, each with an initial body weight of 40.5 ± 4.24 kg, were selected and randomly allocated to receive one of three treatments: ZnO, Zn-lysine, and nano-ZnO supplementation. Each calf received 80 mg of Zn daily. Supplementation with nano-ZnO increased dry matter intake (P < 0.01), average daily gain (P < 0.01), and hip width (P < 0.01) compared to Zn-lysine and ZnO. However, there were no differences in feed conversion ratio. The treatments did not affect apparent digestibility or rumen fermentation, except for a lower rumen ammonia nitrogen concentration in the nano-ZnO group compared to the other two treatments (P < 0.01). Regarding blood parameters, calves receiving Nano-ZnO showed higher blood triglyceride concentration (P = 0.04) and superoxide dismutase activity (P < 0.01), while blood D-lactate concentration was lower in the nano-ZnO and Zn-lysine groups than in the ZnO group (P = 0.01). Additionally, both fecal consistency (P = 0.02) and nasal discharge (P < 0.01) scores were significantly reduced in the nano-ZnO group. In summary, the study suggests that nano-ZnO is a more effective Zn source and an efficient additive for improving dairy calf performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.